A detailed history of Dimensional Fund Advisors LP transactions in Neogenomics Inc stock. As of the latest transaction made, Dimensional Fund Advisors LP holds 3,358,647 shares of NEO stock, worth $55 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
3,358,647
Previous 3,324,624 1.02%
Holding current value
$55 Million
Previous $46.1 Million 7.43%
% of portfolio
0.01%
Previous 0.01%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

BUY
$13.4 - $17.73 $455,908 - $603,227
34,023 Added 1.02%
3,358,647 $49.5 Million
Q2 2024

Aug 09, 2024

BUY
$13.01 - $15.77 $2.83 Million - $3.43 Million
217,687 Added 7.01%
3,324,624 $46.1 Million
Q1 2024

May 10, 2024

BUY
$14.06 - $16.79 $1.41 Million - $1.69 Million
100,414 Added 3.34%
3,106,937 $48.8 Million
Q4 2023

Feb 07, 2024

BUY
$11.67 - $20.73 $217,097 - $385,640
18,603 Added 0.62%
3,006,523 $48.6 Million
Q3 2023

Nov 09, 2023

BUY
$12.15 - $17.85 $91,683 - $134,696
7,546 Added 0.25%
2,987,920 $36.8 Million
Q2 2023

Aug 09, 2023

BUY
$14.1 - $19.83 $4.06 Million - $5.71 Million
287,767 Added 10.69%
2,980,374 $47.9 Million
Q1 2023

May 12, 2023

BUY
$9.09 - $19.45 $8.2 Million - $17.5 Million
902,024 Added 50.38%
2,692,607 $46.9 Million
Q4 2022

Feb 09, 2023

BUY
$6.45 - $12.07 $5.27 Million - $9.86 Million
816,712 Added 83.86%
1,790,583 $16.5 Million
Q3 2022

Nov 10, 2022

SELL
$7.86 - $12.91 $1.97 Million - $3.23 Million
-250,303 Reduced 20.45%
973,871 $8.39 Million
Q2 2022

Aug 12, 2022

SELL
$7.06 - $13.97 $1.35 Million - $2.68 Million
-191,804 Reduced 13.55%
1,224,174 $9.98 Million
Q1 2022

May 13, 2022

SELL
$12.15 - $35.28 $1.46 Million - $4.23 Million
-119,878 Reduced 7.81%
1,415,978 $17.2 Million
Q4 2021

Feb 09, 2022

BUY
$30.49 - $48.49 $4.72 Million - $7.5 Million
154,691 Added 11.2%
1,535,856 $52.4 Million
Q3 2021

Nov 12, 2021

BUY
$41.66 - $52.52 $13.1 Million - $16.5 Million
314,094 Added 29.44%
1,381,165 $66.6 Million
Q2 2021

Aug 12, 2021

BUY
$36.62 - $51.69 $5.37 Million - $7.59 Million
146,755 Added 15.95%
1,067,071 $48.2 Million
Q1 2021

May 14, 2021

SELL
$41.56 - $59.88 $11.4 Million - $16.4 Million
-273,883 Reduced 22.93%
920,316 $44.4 Million
Q4 2020

Feb 25, 2021

BUY
$36.08 - $56.47 $43.1 Million - $67.4 Million
1,194,199 New
1,194,199 $64.3 Million

Others Institutions Holding NEO

About NEOGENOMICS INC


  • Ticker NEO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 125,796,000
  • Market Cap $2.06B
  • Description
  • NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...
More about NEO
Track This Portfolio

Track Dimensional Fund Advisors LP Portfolio

Follow Dimensional Fund Advisors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dimensional Fund Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on Dimensional Fund Advisors LP with notifications on news.